© The American Society of Gene & Cell Therapy original article The Extragenic Spacer Length Between the 5 ′ and 3 ′ Ends of the Transgene Expression Cassette Affects Transgene Silencing From Plasmid-based Vectors

In quiescent tissues, minicircle DNA vectors provide at least 10 times higher sustained levels of transgene expression compared to that achieved with a canonical plasmid containing the same expression cassette. It is not known if there is a specific DNA sequence or structure that is needed for DNA silencing. To directly address this question, we substituted the bacterial plasmid DNA with various lengths of extragenic spacer DNAs between the 5' and 3' ends of the transgene expression cassette and determined the expression profiles using two different reporter expression cassettes. Both the human alphoid repeat (AR) and randomly generated DNA sequences of ≥1 kb in length resulted in transgene silencing while shorter spacers, ≤500 bp exhibited similar transgene expression patterns to conventional minicircle DNA vectors. In contrast, when the ≥1 kb random DNA (RD) sequences were expressed as part of the 3'-untranslated region (UTR) transgene silencing was not observed. These data suggest that the length and not the sequence or origin of the extragenic DNA flanking the expression cassette is responsible for plasmid-mediated transgene silencing. This has implications for the design of nonviral vectors for gene transfer applications as well as providing insights into how genes are regulated.

[1]  M. Kay,et al.  Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. , 2005, Human gene therapy.

[2]  M. Kay,et al.  A Simple And Rapid Minicircle DNA Vector Manufacturing System , 2010, Nature Biotechnology.

[3]  M. Kay,et al.  Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo , 2004, Gene Therapy.

[4]  T. Sauerbruch,et al.  Minimal size MIDGE vectors improve transgene expression in vivo. , 2007, In vivo.

[5]  D. Scherman,et al.  A new DNA vehicle for nonviral gene delivery: supercoiled minicircle , 1997, Gene Therapy.

[6]  Cizhong Jiang,et al.  Nucleosome positioning and gene regulation: advances through genomics , 2009, Nature Reviews Genetics.

[7]  M. Kay,et al.  A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo. , 2002, Blood.

[8]  M. Kay,et al.  Histone Modifications Are Associated with the Persistence or Silencing of Vector-mediated Transgene Expression in Vivo , 2022 .

[9]  C. Coutelle,et al.  An araC-controlled Bacterialcre Expression System to Produce DNA Minicircle Vectors for Nuclear and Mitochondrial Gene Therapy* , 2001, The Journal of Biological Chemistry.

[10]  Arend Sidow,et al.  An in vitro-identified high-affinity nucleosome-positioning signal is capable of transiently positioning a nucleosome in vivo , 2010, Epigenetics & Chromatin.

[11]  M. Schleef,et al.  Minicircle‐DNA production by site specific recombination and protein–DNA interaction chromatography , 2008, The journal of gene medicine.

[12]  M. Kay,et al.  Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  Antonin Morillon,et al.  Gene loops juxtapose promoters and terminators in yeast , 2004, Nature Genetics.

[14]  J. Siedlecki,et al.  Regulatory functions of 3'UTRs. , 2001, Biochemical and biophysical research communications.

[15]  M. Kay,et al.  Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  Michael Hampsey,et al.  A role for the CPF 3'-end processing machinery in RNAP II-dependent gene looping. , 2005, Genes & development.

[17]  Theresa A. Storm,et al.  Extrachromosomal Recombinant Adeno-Associated Virus Vector Genomes Are Primarily Responsible for Stable Liver Transduction In Vivo , 2001, Journal of Virology.